anvumetostat — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-31 in 4mo
ESTIMATED |
READOUT
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC
Phase 2 · MTAP-deleted NSCLC |
AMGN AMGEN INC | anvumetostat |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|